Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02135's Days Inventory is ranked worse than 55.24% of 496
companies
in the Healthcare Providers & Services industry
Industry Median: 29.145
vs HKSE:02135: 32.33
Inventory Turnover measures how fast the company turns over its inventory within a year.
Raily Aesthetic Medicine International Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 7.19.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Raily Aesthetic Medicine International Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.07.
Raily Aesthetic Medicine International Holdings (HKSE:02135) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Raily Aesthetic Medicine International Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Raily Aesthetic Medicine International Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Raily Aesthetic Medicine International Holdings Days Inventory Related Terms
Raily Aesthetic Medicine International Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings Days Inventory Chart
Raily Aesthetic Medicine International Holdings Annual Data
HKSE:02135 vs HCA, THC, DVA: Days Inventory Comparison
For the Medical Care Facilities subindustry, Raily Aesthetic Medicine International Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Raily Aesthetic Medicine International Holdings Days Inventory vs Healthcare Providers & Services Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Raily Aesthetic Medicine International Holdings (HKSE:02135) has a Days Inventory of 25.37 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Raily Aesthetic Medicine International Holdings and its competitors. This is 33% below median its historical median of 37.70. Over the past decade, Raily Aesthetic Medicine International Holdings' Days Inventory has ranged from 28.57 to 50.83. According to the industry distribution chart, Raily Aesthetic Medicine International Holdings ranks #274 out of 496 companies in the Healthcare Providers & Services industry, placing it in the top 55.2%.
Is Raily Aesthetic Medicine International Holdings' Days Inventory too high?
Raily Aesthetic Medicine International Holdings' current Days Inventory of 25.37 is 33% below median its 10-year median of 37.70. Over the past 10 years, this metric has ranged from a low of 28.57 to a high of 50.83. The Healthcare Providers & Services industry median Days Inventory is 29.15. Raily Aesthetic Medicine International Holdings' value of 25.37 is 13% below this industry median. Based on the distribution chart, Raily Aesthetic Medicine International Holdings ranks #274 out of 496 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Raily Aesthetic Medicine International Holdings has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raily Aesthetic Medicine International Holdings' Days Inventory compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Raily Aesthetic Medicine International Holdings ranks #274 out of 496 companies for Days Inventory. This places Raily Aesthetic Medicine International Holdings in the lower half of its industry. The industry median Days Inventory is 29.15. Raily Aesthetic Medicine International Holdings' value of 25.37 is 13% below this benchmark. Historically, Raily Aesthetic Medicine International Holdings' own Days Inventory has ranged from 28.57 to 50.83 over the past decade. While the company's 10-year median is 37.70 vs. the industry median of 29.15, Raily Aesthetic Medicine International Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Healthcare Providers & Services company?
The median Days Inventory among Healthcare Providers & Services companies is 29.15, based on 496 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Raily Aesthetic Medicine International Holdings's current Days Inventory of 25.37 is 13% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Raily Aesthetic Medicine International Holdings and its competitors. For the Healthcare Providers & Services industry, the median Days Inventory is 29.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Raily Aesthetic Medicine International Holdings's current Days Inventory is 25.37, which is 33% below median its own 10-year median of 37.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raily Aesthetic Medicine International Holdings stock overvalued right now?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings (HKSE:02135) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.14, compared to a current price of HK$0.12 — trading 15% below its estimated fair value. The current Days Inventory is 25.37, which is 33% below median its 10-year median of 37.70 and 13% below the Healthcare Providers & Services industry median of 29.15. Raily Aesthetic Medicine International Holdings' overall GF Score™ is 47/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Raily Aesthetic Medicine International Holdings (HKSE:02135), the current Days Inventory is 25.37 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Raily Aesthetic Medicine International Holdings (HKSE:02135) Overvalued in 2026?
Based on GuruFocus' analysis, Raily Aesthetic Medicine International Holdings stock appears to be undervalued.
The current stock price of HK$0.12 is trading 15% below its estimated GF Value™ of HK$0.14.
GuruFocus considers Raily Aesthetic Medicine International Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02135:
Days Inventory: 25.37 (33% below median its 10-year median of 37.70)
GF Value™: HK$0.14 vs. price of HK$0.12 (15% below fair value)
Industry Position: 13% below the Healthcare Providers & Services median (#274 of 496)
No single metric tells the full story. See the HKSE:02135 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Raily Aesthetic Medicine International Holdings Ltd is an investment holding company. The company were principally engaged in the provision of aesthetic medical services, sale of aesthetic medical equipment products and provision of consulting services. The group is organized into three reportable operating segments namely Aesthetic medical services comprise principally inpatient services including surgical services and outpatient services including injection service, dermatology service and others; Aesthetic medical equipment products comprise principally sales of collagen injection products, surgical implants and aesthetic medical skincare products; Consulting services comprise principally management consulting services of which majority of revenue comes from Aesthetic medical services.
47GF Score
Get the complete analysis for HKSE:02135
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02135 has been successfully added to your 
